You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

doxorubicin

Showing 1 - 25 of 426
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, KRAS Mutation-Related Tumors Trial in Washington (NEROFE, Doxorubicin)

Recruiting
  • Solid Tumor
  • KRAS Mutation-Related Tumors
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Jan 23, 2023

Breast Cancer Trial (Nanoxel M, Taxotere, Doxorubicin)

Not yet recruiting
  • Breast Cancer
  • Nanoxel M
  • +3 more
  • (no location specified)
Jan 20, 2022

Sarcoma Trial in Boston (Bevacizumab, Doxorubicin, Radiation Therapy)

Active, not recruiting
  • Sarcoma
  • Boston, Massachusetts
    Massachusetts General Hospital
Apr 6, 2022

Sarcoma Trial in Santa Monica (Gemcitabine, Doxorubicin, Docetaxel)

Recruiting
  • Sarcoma
  • Santa Monica, California
    Sant P Chawla
May 4, 2022

Advanced Sarcoma, Metastatic Sarcoma, Soft Tissue Sarcoma Trial (YH001, Envafolimab, Doxorubicin)

Not yet recruiting
  • Advanced Sarcoma
  • +2 more
  • (no location specified)
Jul 3, 2022

Advanced Soft-tissue Sarcoma Trial in Nicosia, Amman (Doxorubicin, Cyclophosphamide Oral Product, Prednisolone)

Recruiting
  • Advanced Soft-tissue Sarcoma
  • Doxorubicin
  • +3 more
  • Nicosia, Cyprus
  • +1 more
Jul 1, 2022

Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma, Advanced Leiomyosarcoma Trial in Boston (Lurbinectedin,

Recruiting
  • Advanced Soft-tissue Sarcoma
  • +3 more
  • Boston, Massachusetts
  • +1 more
Feb 14, 2022

Brain Tumor Trial in Washington (Exablate, Doxorubicin)

Recruiting
  • Brain Tumor
  • Exablate
  • Doxorubicin
  • Washington, District of Columbia
    Children's National Medical Center
Jan 4, 2023

Brain Tumor Trial in Toronto (Exablate, Doxorubicin)

Recruiting
  • Brain Tumor
  • Exablate
  • Doxorubicin
  • Toronto, Ontario, Canada
    Sunnybrook Research Institute
Jan 5, 2023

Soft Tissue Sarcoma Trial in Worldwide (Onfekafusp alfa, Doxorubicin)

Recruiting
  • Soft Tissue Sarcoma
  • Onfekafusp alfa
  • Doxorubicin
  • Bad Saarow, Germany
  • +8 more
Apr 8, 2022

Ovarian Cancer Trial in Pittsburgh (Pembrolizumab, ALX148, Doxorubicin)

Not yet recruiting
  • Ovarian Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 19, 2022

Sensitivity to Doxorubicin/Doxil in Soft Tissue Sarcoma

Active, not recruiting
  • Soft Tissue Sarcoma
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jan 24, 2022

Uterine or Soft Tissue Leiomyosarcoma Trial in Villejuif (Doxorubicin, Trabectedin)

Completed
  • Uterine or Soft Tissue Leiomyosarcoma
  • Villejuif, Val De Marne, France
    Gustave Roussy
Dec 10, 2021

Soft Tissue Sarcoma Trial in Toronto (Selinexor, Doxorubicin)

Completed
  • Soft Tissue Sarcoma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Nov 26, 2021

Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV, Pancreatic Cancer Non-resectable Trial in Oxford (Focused

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +3 more
  • Focused Ultrasound
  • +2 more
  • Oxford, United Kingdom
    Oxford University Hospitals NHS Trust
Feb 22, 2022

Soft Tissue Sarcoma Trial in New York (Doxorubicin, APX005M)

Recruiting
  • Soft Tissue Sarcoma
  • New York, New York
    Columbia University Medical Center
Nov 12, 2021

Pancreas Cancer Trial in Scottsdale, Morristown, Milwaukee (L-DOS47, Doxorubicin)

Recruiting
  • Pancreas Cancer
  • L-DOS47
  • Doxorubicin
  • Scottsdale, Arizona
  • +2 more
Mar 16, 2022

Metastatic Soft-tissue Sarcoma Trial in United States (NOX66, Doxorubicin)

Recruiting
  • Metastatic Soft-tissue Sarcoma
  • Duarte, California
  • +3 more
Jul 12, 2022

Solid Tumor, Urethral Cancer Trial in Houston (Bortezomib, Gemcitabine, Doxorubicin)

Active, not recruiting
  • Solid Tumor
  • Urethral Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 21, 2022

Advanced Solid Tumors Amenable to Anthracycline Therapy, Sarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer

Completed
  • Advanced Solid Tumors Amenable to Anthracycline Therapy
  • Sarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer Amenable to Anthracycline Therapy
  • Münster, Germany
  • +1 more
Apr 1, 2022

Leiomyosarcoma Trial in United States (Doxorubicin, L19TNF plus doxorubicin)

Recruiting
  • Leiomyosarcoma
  • Doxorubicin
  • L19TNF plus doxorubicin
  • Phoenix, Arizona
  • +7 more
Apr 7, 2022

Adult T-cell Leukemia/Lymphoma, Extranodal NK-/T-cell Lymphoma, Nasal Type, Enteropathy-Associated T-Cell Lymphoma Trial run by

Not yet recruiting
  • Adult T-cell Leukemia/Lymphoma
  • +4 more
  • CC-486 (5-azacitidine)
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in France (Bintrafusp alfa, Doxorubicin)

Recruiting
  • Advanced Soft-tissue Sarcoma
  • Metastatic Soft-tissue Sarcoma
  • Bintrafusp alfa
  • Doxorubicin
  • Bordeaux, France
  • +7 more
Dec 6, 2021

Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in Toulouse (Doxorubicin, Cyclophosphamide)

Recruiting
  • Advanced Soft-tissue Sarcoma
  • Metastatic Soft-tissue Sarcoma
  • Toulouse, France
    Institut Claudius Reagaud-IUCT Oncopôle
Sep 27, 2021

Triple Negative Breast Cancer Trial in Chicago (Carboplatin, Paclitaxel, Doxorubicin)

Active, not recruiting
  • Triple Negative Breast Cancer
  • Chicago, Illinois
    University of Illinois
Jan 28, 2022